Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago.
Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per d
Evaluate the expected performance of Inspire (INSP) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
New York State Common Retirement Fund trimmed its holdings in Inspire Medical Systems, Inc. (NYSE: INSP) by 73.7% in the third quarter, according to its most recent disclosure with the Securities and
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has comme
NEW YORK, Jan. 30, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP)  brea
Baillie Gifford and Co. lowered its holdings in Inspire Medical Systems, Inc. (NYSE: INSP) by 2.7% during the undefined quarter, according to the company in its most recent disclosure with the Securit
Shares of Inspire Medical Systems, Inc. (NYSE: INSP - Get Free Report) have been assigned an average rating of "Hold" from the nineteen analysts that are currently covering the stock, Marketbeat repor
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (N
INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.
Inspire Medical Systems, Inc. (NYSE: INSP - Get Free Report) insider John Rondoni sold 109 shares of Inspire Medical Systems stock in a transaction dated Friday, January 9th. The shares were sold at a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE